a8b59e40f348c17c57e23836061c83b6.jpg

Black Buffalo 3D and FITTLE partner to bring 3DCP to market Construction 3D Printing

Black Buffalo 3D Corporation, a leading provider of large-scale 3D construction printers, has entered a strategic partnership with FITTLE – the equipment financing business of Xerox Holdings Corporation that rebranded as FITTLE in 2022, and is a leading provider of innovative business financing and payment solutions – to help bring the company’s pioneering 3D concrete printing technology to market.

61f198000bd33fec47d4d4bd5fc96a8d.jpg

Intertronics supports University of Sheffield with bioelectronics research Research & Education

When the Department of Automatic Control and Systems Engineering (ACSE) at The University of Sheffield was looking for a way to accurately 3D print bioelectronic sensors, it reached out to Intertronics for support. The company supplied mixing and dispensing equipment to improve the consistency and quality of the mix – achieve better printing definition and reduced blockages in the nozzle of the 3D printer.

PostProcess launches CONNECT3D AM platform Additive Manufacturing

PostProcess Launches CONNECT3D AM Platform

PostProcess Technologies, the pioneer of automated and intelligent post-printing solutions for industrial 3D printing, today has made known that its CONNECT3D Additive Manufacturing Platform is now available. The CONNECT3D platform is a new addition to the company’s current full-stack solution of hardware, chemistry, and software and complements the current AUTOMAT3D software application.

Prellis Biologics to provide human lymph node organoids for research Bioprinting

Prellis Biologics to Provide Human Lymph Node Organoids for Research

Prellis Biologics Inc., a biotherapeutics company with human tissue engineering capabilities, has entered into a collaboration and license option agreement with Sanofi S.A., an innovative global healthcare company. The collaboration will focus on the discovery of antibodies with Prellis’ first-in-class external human immune system (EXIS), and leverages Prellis’ ability to engineer fully-human lymph node organoids (LNOs) and recreate immune responses in vitro to deliver antibodies with significant genetic diversity.